Teva Branded Pharmaceutical Products R&D LLC $TEVA
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-32
RECRUITING1
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO20%
Delay Index: of 5 active trials registered more than a year ago, 1 have moved their primary completion (readout) date by more than 6 months since first registration (median +3.9 months). See all sponsors →
Open Teva Branded Pharmaceutical Products R&D LLC on the live radar map → 📅 $TEVA readout calendar (.ics)| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| TEV-48574 Dose Regimen A NCT05668013 |
P2 | Active, not recruiting | Crohn Disease; Colitis, Ulcerative | 247 | 2026-01-05 (+12 mo) |
| TEV-53408 NCT06807463 |
P2 | Active, not recruiting | Celiac Disease | 50 | 2026-10-02 (+2 mo) |
| TEV-56248 NCT06052267 |
P3 | Active, not recruiting | Asthma | 2769 | 2026-12-31 (+5 mo) |
| TOPAS-MSA NCT06568237 |
P2 | Active, not recruiting | Multiple System Atrophy | 349 | 2027-09-15 (+4 mo) |
| TEV-56286 NCT07197866 |
P2 | Recruiting | Multiple System Atrophy | 200 | 2029-05-03 |
| TEV-53408 Dose A NCT07920211 |
P2/3 | Not yet recruiting | Vitiligo | 1020 | 2030-09-12 |